All Stories

  1. A Novel Humanized Antibody Neutralizes H5N1 Influenza Virus via Two Different Mechanisms
  2. Progress toward a Universal H5N1 Vaccine: A Recombinant Modified Vaccinia Virus Ankara-Expressing Trivalent Hemagglutinin Vaccine
  3. Cross-protective efficacy of baculovirus displayed hemagglutinin against highly pathogenic influenza H7 subtypes
  4. Monovalent H5 vaccine based on epitope-chimeric HA provides broad cross-clade protection against variant H5N1 viruses in mice
  5. Effective intranasal therapeutics and prophylactics with monoclonal antibody against lethal infection of H7N7 influenza virus
  6. Microbes and Livestock
  7. Cross-protective efficacy of bivalent recombinant baculoviral vaccine against heterologous influenza H5N1 challenge
  8. Development of A Sensitive and Specific Epitope-Blocking ELISA for Universal Detection of Antibodies to Human Enterovirus 71 Strains
  9. Monoclonal Antibody Targeting Neutralizing Epitope on H5N1 Influenza Virus of Clade 1 and 0 for Specific H5 Quantification
  10. Development of dual-function ELISA for effective antigen and antibody detection against H7 avian influenza virus
  11. Characterization and specificity of the linear epitope of the enterovirus 71 VP2 protein
  12. A Novel Peptide ELISA for Universal Detection of Antibodies to Human H5N1 Influenza Viruses
  13. Complementary monoclonal antibody-based dot ELISA for universal detection of H5 avian influenza virus
  14. Evaluation of a Subunit H5 Vaccine and an Inactivated H5N2 Avian Influenza Marker Vaccine in Ducks Challenged with Vietnamese H5N1 Highly Pathogenic Avian Influenza Virus
  15. Combination Therapy Using Chimeric Monoclonal Antibodies Protects Mice from Lethal H5N1 Infection and Prevents Formation of Escape Mutants
  16. Baculovirus vector as a delivery vehicle for influenza vaccines
  17. Development of Epitope-Blocking ELISA for Universal Detection of Antibodies to Human H5N1 Influenza Viruses
  18. Immunohistochemical detection of Influenza virus infection in formalin-fixed tissues with anti-H5 monoclonal antibody recognizing FFWTILKP
  19. Protective immunity against influenza H5N1 virus challenge in mice by intranasal co-administration of baculovirus surface-displayed HA and recombinant CTB as an adjuvant
  20. Identification and characterization of a new E3 ubiquitin ligase in white spot syndrome virus involved in virus latency
  21. WSSV ie1 promoter is more efficient than CMV promoter to express H5 hemagglutinin from influenza virus in baculovirus as a chicken vaccine